Stocks & Equities
I love reading about all the good news in the market. This past week, we saw U.S. jobless claims dip to 211,000, and they are now near half-century lows. We also saw U.S. consumer sentiment reach a 15-year high. So, what could go wrong? CLICK for complete article


Trump surprised stock markets today following some encouraging statements regarding the ongoing trade spat between the U.S. and China.
Stock markets rose at the opening bell on Friday morning, a day after a sharp sell-off, as sentiment was damaged by observations from President Donald Trump planning for a speedy end to the extended trade war with China….CLICK for complete article

Since the Great Recession, there has been an explosion of interest and activity in the tech startup arena. Tens of thousands of tech startups have been founded in recent years and there are now over three hundred new “unicorn” startups that have valuations of $1 billion or more. The startup gold rush began as countless entrepreneurs attempted to follow in the footsteps of Facebook founder Mark Zuckerberg and the “Google Guys,” Larry Page and Sergey Brin. Unfortunately, the majority of today startups – including today’s hottest unicorns – are burning copious amounts of cash. In this piece, I will make the case that today’s startup phenomenon is very similar to China’s construction of countless empty “ghost cities” for the purpose of creating jobs and economic growth…..CLICK for complete article

Bicycle Therapeutics, which derives its name from a novel class of medicines it develops, is riding its way toward a Nasdaq listing.
Bicycle is a clinical-stage biopharma company and uses a novel class of medicines known as bicycles: synthetic short peptides constrained to form two loops, which provides stability and selectivity.
This unique therapeutic modality combines the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule…..CLICK for complete article
